GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » EGF Theramed Health Corp (XCNQ:TMED) » Definitions » Research & Development

EGF Theramed Health (XCNQ:TMED) Research & Development : C$0.00 Mil (TTM As of Dec. 2023)


View and export this data going back to 2013. Start your Free Trial

What is EGF Theramed Health Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. EGF Theramed Health's Research & Development for the three months ended in Dec. 2023 was C$0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 was C$0.00 Mil.

EGF Theramed Health Research & Development Historical Data

The historical data trend for EGF Theramed Health's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EGF Theramed Health Research & Development Chart

EGF Theramed Health Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.22 0.04 - - -

EGF Theramed Health Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

EGF Theramed Health Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EGF Theramed Health  (XCNQ:TMED) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

EGF Theramed Health Research & Development Related Terms

Thank you for viewing the detailed overview of EGF Theramed Health's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

EGF Theramed Health (XCNQ:TMED) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » EGF Theramed Health Corp (XCNQ:TMED) » Definitions » Research & Development
Comparable Companies
XCNQ:NARA TSXV:PTEC XCNQ:LITE XCNQ:DMED XCNQ:TRUE XCNQ:CBP TSXV:CHS TSXV:EKG TSXV:MNOW TSXV:KOVO VEEV GEHC TSE:2413 HQY ASX:PME RCM TXG DOCS PGNY EVH
Traded in Other Exchanges
EVAHF:USA AUH:Germany
Address
609 Granville Street, Suite 1600, P.O. Box 10068,, Pacific Centre, Vancouver, BC, CAN, V7Y 1C3
Website
https://www.egftheramedhealth.com
EGF Theramed Health Corp is an early-stage development company. It develops products, technologies, and diagnostic tools focused on personalized medical care including research with natural health and wellness products. The products serve the overall goal of improving health and elevating the human condition. The company explores many other medical areas including weight loss, skincare and heart disease.